{
    "Trade/Device Name(s)": [
        "QuikScreen Multi (MDMA and OPI) Drug Cup Test"
    ],
    "Submitter Information": "Tianjin New Bay Bioresearch Co., Ltd.",
    "510(k) Number": "K130275",
    "Predicate Device Reference 510(k) Number(s)": [
        "K121166",
        "K071489"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LAF",
        "DJG"
    ],
    "Summary Letter Date": "August 21, 2013",
    "Summary Letter Received Date": "August 26, 2013",
    "Submission Date": "May 29, 2012",
    "Regulation Number(s)": [
        "21 CFR 862.3650",
        "21 CFR 862.3610"
    ],
    "Regulation Name(s)": [
        "Opiate test system",
        "MDMA test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "MDMA",
        "Opiates"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [
        "Specimen collection cup"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Lateral flow immunochromatographic assay",
        "Competitive binding assay"
    ],
    "Methodologies": [
        "Immunoassay",
        "Lateral flow"
    ],
    "Submission Type(s)": [
        "Test",
        "Specimen collection device",
        "Cup",
        "Strip test"
    ],
    "Document Summary": "FDA 510(k) summary for QuikScreen Multi (MDMA and OPI) Drug Cup Test, a rapid lateral flow immunoassay urine drug screening cup for MDMA and opiates.",
    "Indications for Use Summary": "Screening device for detection of MDMA (\u2265500 ng/mL) and opiates (\u2265300 ng/mL) in human urine for prescription and OTC use; provides preliminary results requiring confirmatory testing.",
    "fda_folder": "Toxicology"
}